Regulatory T cell inhibition by dasatinib is associated with natural killer cell differentiation and a favorable molecular response—The final results of the D-first study

JOURNAL ARTICLE published March 2018 in Leukemia Research

Authors: Yuho Najima | Chikashi Yoshida | Noriyoshi Iriyama | Shin Fujisawa | Hisashi Wakita | Shigeru Chiba | Shinichiro Okamoto | Kimihiro Kawakami | Naoki Takezako | Takashi Kumagai | Kazuma Ohyashiki | Jun Taguchi | Shingo Yano | Tadahiko Igarashi | Yasuji Kouzai | Satoshi Morita | Junichi Sakamoto | Hisashi Sakamaki | Koiti Inokuchi